• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中,miR-512表达降低及其靶标cFLIP和MCL1表达升高定位于tau蛋白高度磷酸化的神经元。

Reduced miR-512 and the Elevated Expression of Its Targets cFLIP and MCL1 Localize to Neurons With Hyperphosphorylated Tau Protein in Alzheimer Disease.

作者信息

Mezache Louisa, Mikhail Madison, Garofalo Michela, Nuovo Gerard J

机构信息

*Phylogeny Inc. †OSU Comprehensive Cancer Center, Columbus, OH.

出版信息

Appl Immunohistochem Mol Morphol. 2015 Oct;23(9):615-23. doi: 10.1097/PAI.0000000000000147.

DOI:10.1097/PAI.0000000000000147
PMID:26258756
Abstract

The cause for the neurofibrillary tangles and plaques in Alzheimer disease likely relates to an abnormal accumulation of their key components, which include β-amyloid and hyperphosphorylated tau protein. We segregated Alzheimer brain sections from people with end-stage disease into those with abundant hyperphosphorylated tau protein and those without and compared each to normal brains for global microRNA patterns. A significant reduced expression of several microRNAs, including miR-512, was evident in the Alzheimer brain sections with abundant hyperphosphorylated tau. Immunohistochemistry documented that 2 known targets of microRNA-512, cFLIP and MCL1, were significantly over expressed and each colocalized to neurons with the abnormal tau protein. Analysis for apoptosis including activated caspase-3, increased caspase-4 and caspase-8, apoptosis initiating factor, APAF-1 activity, and the TUNEL assay was negative in the areas where neurons showed hyperphosphorylated tau. MCM2 expression, a marker of neuroprogenitor cells, was significantly reduced in the Alzheimer sections that contained the hyperphosphorylated tau. These results suggest that a basic defect in Alzheimer disease may be the reduced microRNA-driven increased expression of proteins that may alter the apoptotic/antiapoptotic balance of neurons. This, in turn, could lead to the accumulation of key Alzheimer proteins such as hyperphosphorylated tau that ultimately prevent normal neuronal function and lead to disease symptomatology.

摘要

阿尔茨海默病中神经原纤维缠结和斑块的病因可能与它们关键成分的异常积累有关,这些关键成分包括β-淀粉样蛋白和过度磷酸化的tau蛋白。我们将晚期阿尔茨海默病患者的脑切片分为富含过度磷酸化tau蛋白的切片和不含过度磷酸化tau蛋白的切片,并将每一组与正常脑切片进行整体微小RNA模式比较。在富含过度磷酸化tau蛋白的阿尔茨海默病脑切片中,包括miR-512在内的几种微小RNA的表达明显降低。免疫组织化学证明,微小RNA-512的两个已知靶标cFLIP和MCL1明显过度表达,且均与异常tau蛋白共定位于神经元。在神经元显示过度磷酸化tau的区域,包括活化的半胱天冬酶-3、增加的半胱天冬酶-4和半胱天冬酶-8、凋亡起始因子、凋亡蛋白酶激活因子-1活性以及TUNEL检测在内的凋亡分析均为阴性。神经祖细胞标志物MCM2的表达在含有过度磷酸化tau的阿尔茨海默病切片中明显降低。这些结果表明,阿尔茨海默病的一个基本缺陷可能是微小RNA驱动的可能改变神经元凋亡/抗凋亡平衡的蛋白质表达增加减少。反过来,这可能导致阿尔茨海默病关键蛋白如过度磷酸化tau的积累,最终阻止正常神经元功能并导致疾病症状。

相似文献

1
Reduced miR-512 and the Elevated Expression of Its Targets cFLIP and MCL1 Localize to Neurons With Hyperphosphorylated Tau Protein in Alzheimer Disease.阿尔茨海默病中,miR-512表达降低及其靶标cFLIP和MCL1表达升高定位于tau蛋白高度磷酸化的神经元。
Appl Immunohistochem Mol Morphol. 2015 Oct;23(9):615-23. doi: 10.1097/PAI.0000000000000147.
2
Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.磷酸化丝裂原活化蛋白激酶(MAPK/ERK-P)、38 kDa蛋白激酶(p38-P)、应激激活蛋白激酶(SAPK/JNK-P)和钙/钙调蛋白依赖性激酶II(CaM激酶II)在tau蛋白病的神经元和神经胶质细胞的tau沉积物中差异表达。
J Neural Transm (Vienna). 2001;108(12):1397-415. doi: 10.1007/s007020100016.
3
miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.在阿尔茨海默病模型中,miR-106b通过靶向Fyn抑制Tyr18位点的tau蛋白磷酸化。
Biochem Biophys Res Commun. 2016 Sep 16;478(2):852-7. doi: 10.1016/j.bbrc.2016.08.037. Epub 2016 Aug 9.
4
Co-localization of hyperphosphorylated tau and caspases in the brainstem of Alzheimer's disease patients.阿尔茨海默病患者脑干中过度磷酸化tau蛋白与半胱天冬酶的共定位。
Biogerontology. 2009 Aug;10(4):457-69. doi: 10.1007/s10522-008-9189-8. Epub 2008 Oct 23.
5
Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers.人类免疫缺陷病毒阴性阿片类药物滥用者大脑中加速出现与阿尔茨海默病相关变化的易感性。
Brain. 2010 Dec;133(Pt 12):3685-98. doi: 10.1093/brain/awq263.
6
Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.糖原合酶激酶-3与阿尔茨海默病、皮克病、进行性核上性麻痹和皮质基底节变性中的神经元和胶质细胞过度磷酸化tau蛋白沉积有关。
Acta Neuropathol. 2002 Dec;104(6):583-91. doi: 10.1007/s00401-002-0587-8. Epub 2002 Jul 13.
7
Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.α1-抗糜蛋白酶是一种在阿尔茨海默病大脑中过度表达的炎症蛋白,可诱导神经元中的tau蛋白磷酸化。
Brain. 2006 Nov;129(Pt 11):3020-34. doi: 10.1093/brain/awl255. Epub 2006 Sep 20.
8
An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.一种基于铝的阿尔茨海默病大鼠模型表现出氧化损伤、蛋白磷酸酶2A(PP2A)活性抑制、tau蛋白过度磷酸化和颗粒空泡变性。
J Inorg Biochem. 2007 Sep;101(9):1275-84. doi: 10.1016/j.jinorgbio.2007.06.001. Epub 2007 Jun 12.
9
Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease.阿尔茨海默病中tau蛋白磷酸化位点与神经元凋亡的关联
J Neurol Sci. 2003 Apr 15;208(1-2):17-24. doi: 10.1016/s0022-510x(02)00410-0.
10
Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease.与阿尔茨海默病中神经原纤维缠结形成相关的进行性神经元DNA损伤。
J Neuropathol Exp Neurol. 1998 Apr;57(4):323-8. doi: 10.1097/00005072-199804000-00003.

引用本文的文献

1
Therapeutic potential and microRNA regulating properties of phytochemicals in Alzheimer's disease.植物化学物质在阿尔茨海默病中的治疗潜力及对微小RNA的调控特性
Mol Ther Nucleic Acids. 2024 Dec 23;36(1):102439. doi: 10.1016/j.omtn.2024.102439. eCollection 2025 Mar 11.
2
Multi-Omics Analysis of Hippocampus in Rats Administered Trimethyltin Chloride.三甲基氯化锡处理大鼠海马的多组学分析
Neurotox Res. 2025 Mar 17;43(2):13. doi: 10.1007/s12640-025-00737-3.
3
Non-coding RNAs in the pathogenesis of Alzheimer's disease: β-amyloid aggregation, Tau phosphorylation and neuroinflammation.
非编码RNA在阿尔茨海默病发病机制中的作用:β-淀粉样蛋白聚集、 Tau蛋白磷酸化和神经炎症
Mol Biol Rep. 2025 Jan 31;52(1):183. doi: 10.1007/s11033-025-10284-x.
4
MicroRNAs: pioneering regulators in Alzheimer's disease pathogenesis, diagnosis, and therapy.微小 RNA:阿尔茨海默病发病机制、诊断和治疗的先驱调控因子。
Transl Psychiatry. 2024 Sep 10;14(1):367. doi: 10.1038/s41398-024-03075-8.
5
Exploring the Regulatory Landscape of Dementia: Insights from Non-Coding RNAs.探索痴呆症的调控机制:非编码 RNA 的启示。
Int J Mol Sci. 2024 Jun 4;25(11):6190. doi: 10.3390/ijms25116190.
6
Roles of Non-Coding RNA in Alzheimer's Disease Pathophysiology.非编码 RNA 在阿尔茨海默病病理生理学中的作用。
Int J Mol Sci. 2023 Aug 6;24(15):12498. doi: 10.3390/ijms241512498.
7
LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.长链非编码RNA RP11-59J16.2通过靶向MCM2加重阿尔茨海默病中的细胞凋亡并增加tau蛋白磷酸化。
Front Genet. 2022 Aug 26;13:824495. doi: 10.3389/fgene.2022.824495. eCollection 2022.
8
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.微小 RNA 改变、作为生物标志物的应用及在神经退行性疾病中的治疗方法。
Int J Mol Sci. 2022 Apr 25;23(9):4718. doi: 10.3390/ijms23094718.
9
The role of the microRNA regulatory network in Alzheimer's disease: a bioinformatics analysis.微小RNA调控网络在阿尔茨海默病中的作用:一项生物信息学分析
Arch Med Sci. 2021 Mar 18;18(1):206-222. doi: 10.5114/aoms/80619. eCollection 2022.
10
The Role of Non-coding RNAs in Alzheimer's Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers.非编码RNA在阿尔茨海默病中的作用:从调控机制到治疗靶点及诊断生物标志物
Front Aging Neurosci. 2021 Jul 2;13:654978. doi: 10.3389/fnagi.2021.654978. eCollection 2021.